Candriam Equities L Biotech.C USD Dis/ LU0108459552 /
NAV2024-03-27 | Chg.+9.6300 | Type of yield | Investment Focus | Investment company |
---|---|---|---|---|
783.5000USD | +1.24% | paying dividend | Equity Worldwide | Candriam ▶ |
Monthly performance
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2000 | - | - | - | - | 9.07 | 39.65 | -8.01 | 23.69 | 10.72 | -11.24 | -13.74 | 4.18 | - |
2001 | -2.63 | -12.28 | -20.64 | 18.86 | 9.28 | 4.98 | -14.90 | 2.77 | -19.22 | 16.98 | 9.78 | 0.03 | -16.11% |
2002 | -15.77 | -3.67 | 2.35 | -17.67 | 0.46 | -18.95 | 1.99 | 0.98 | -9.50 | 9.48 | 7.67 | -6.84 | -43.02% |
2003 | -4.71 | -4.58 | 6.06 | 7.14 | 20.00 | -3.01 | 7.99 | -2.86 | 2.20 | 2.20 | -1.67 | 6.66 | +38.18% |
2004 | 7.08 | 1.56 | -1.42 | -0.39 | -2.54 | -0.01 | -9.09 | 2.22 | 5.78 | -2.11 | 0.82 | 6.14 | +7.16% |
2005 | -3.81 | -5.20 | -3.96 | 3.01 | 6.36 | 2.85 | 10.12 | 1.25 | 2.79 | -3.41 | 5.67 | 1.28 | +16.90% |
2006 | 6.12 | 3.95 | -3.55 | -4.77 | -4.44 | 0.10 | -2.51 | 2.56 | 0.18 | 13.73 | 0.76 | -2.27 | +8.75% |
2007 | 2.28 | -3.54 | 2.02 | 7.47 | 0.08 | -5.87 | -2.83 | 1.87 | 5.50 | 2.14 | -2.82 | -5.94 | -0.65% |
2008 | -5.04 | -3.45 | 1.52 | 1.40 | 1.64 | -2.69 | 17.00 | -4.27 | -6.57 | -15.63 | -10.18 | 8.04 | -20.02% |
2009 | -1.37 | -7.08 | 6.16 | -0.49 | 2.87 | 7.08 | 29.16 | 2.60 | 1.37 | -11.26 | 7.99 | 5.19 | +44.41% |
2010 | 3.27 | 6.32 | 14.94 | -2.02 | -12.51 | -5.73 | 3.62 | -0.48 | 10.70 | 2.68 | -2.59 | 6.17 | +23.65% |
2011 | -0.64 | 0.71 | 5.91 | 4.52 | 2.93 | -1.77 | -3.57 | -8.02 | -6.69 | 7.92 | 0.70 | 1.77 | +2.53% |
2012 | 11.82 | 0.38 | 5.75 | 0.55 | -2.15 | 5.51 | 2.34 | 1.90 | 5.14 | -5.96 | 4.39 | -1.03 | +31.25% |
2013 | 9.66 | 1.02 | 8.07 | 6.09 | 3.28 | -2.76 | 14.25 | -2.44 | 9.93 | -2.81 | 6.52 | 1.60 | +64.40% |
2014 | 8.24 | 7.34 | -9.94 | -5.10 | 2.76 | 10.10 | -3.25 | 11.05 | -1.11 | 9.59 | 2.97 | 0.57 | +35.47% |
2015 | 4.47 | 4.53 | 1.85 | -5.10 | 10.73 | 0.63 | 4.16 | -10.94 | -11.38 | 7.79 | 3.42 | 0.32 | +8.10% |
2016 | -23.25 | -4.59 | 3.67 | 3.77 | 5.58 | -8.41 | 12.55 | -2.39 | 3.96 | -12.73 | 9.10 | -2.85 | -19.51% |
2017 | 5.50 | 6.83 | 0.08 | 1.07 | -2.96 | 9.36 | 2.39 | 6.81 | 0.89 | -6.61 | 0.12 | 1.45 | +26.62% |
2018 | 6.69 | -4.62 | -2.15 | -3.21 | 4.60 | 0.80 | 4.40 | 4.12 | -2.09 | -14.02 | 4.12 | -8.32 | -11.26% |
2019 | 13.12 | 3.56 | -0.58 | -4.95 | -4.48 | 9.42 | -2.22 | -2.37 | -4.52 | 11.18 | 11.96 | 2.77 | +34.92% |
2020 | -5.29 | -1.54 | -5.00 | 12.34 | 9.48 | 1.27 | -3.02 | 0.83 | 0.70 | -2.66 | 9.43 | 2.97 | +19.20% |
2021 | 1.80 | -2.60 | -4.29 | 2.70 | -2.27 | 6.33 | -1.47 | 3.88 | -4.25 | 0.15 | -4.39 | 2.39 | -2.69% |
2022 | -10.59 | -1.56 | 6.03 | -7.24 | -3.98 | 3.49 | 4.70 | 1.52 | -1.91 | 6.49 | 6.17 | -2.88 | -1.52% |
2023 | 2.90 | -5.68 | 0.23 | 2.26 | -0.96 | 1.41 | -0.59 | -0.24 | -4.50 | -6.13 | 6.14 | 13.61 | +7.13% |
2024 | 1.47 | 1.34 | 0.26 | - | - | - | - | - | - | - | - | - | - |
Single months: Dividends not considered
Calculated values
YTD | 6 Months | 1 Year | 3 Years | 5 Years | |
---|---|---|---|---|---|
Volatility | 15.64% | 18.59% | 15.99% | 20.11% | 22.79% |
Sharpe ratio | 0.64 | 1.71 | 0.75 | 0.02 | 0.20 |
Best month | +13.61% | +13.61% | +13.61% | +13.61% | +13.61% |
Worst month | +0.26% | -6.13% | -6.13% | -10.59% | -10.59% |
Maximum loss | -5.01% | -8.73% | -15.79% | -28.87% | -30.65% |
Outperformance | -4.42% | - | -5.67% | +0.19% | -4.92% |
All quotes in USD
Tranches
Name | Type of yield | Repurchase p. | 1 Year | 3 Years | |
---|---|---|---|---|---|
Candriam Equities L Biotech.V US... | reinvestment | 2,079.8999 | +16.10% | +14.33% | |
Candriam Equities L Biotech.C EU... | reinvestment | 223.2200 | +15.38% | - | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,088.9299 | +13.38% | +6.42% | |
Candriam Equities L Biotech.I EU... | reinvestment | 2,242.2400 | +15.59% | +23.90% | |
Candriam Equities L Biotech.I GB... | reinvestment | 3,455.9900 | +12.71% | +22.95% | |
Candriam Equities L Biotech.R GB... | reinvestment | 363.6200 | +13.59% | +27.14% | |
Candriam Equities L Biotech.R EU... | reinvestment | 328.9000 | +16.46% | +26.76% | |
Candriam Equities L Biotech.R CH... | reinvestment | 204.8800 | +11.72% | +5.39% | |
Candriam Equities L Biotech.V2 U... | reinvestment | 1,865.6000 | +17.18% | +17.47% | |
Candriam Equities L Biotech.N-H ... | reinvestment | 151.9100 | - | - | |
Candriam Equities L Biotech.V US... | reinvestment | 607.9500 | +15.44% | +12.33% | |
Candriam Equities L Biotech.I US... | reinvestment | 5,691.0000 | +15.96% | +13.91% | |
Candriam Equities L Biotech.C EU... | reinvestment | 200.5700 | +14.03% | +6.23% | |
Candriam Equities L Biotech.R US... | reinvestment | 270.5100 | +16.88% | +16.59% | |
Candriam Equities L Biotech.R EU... | reinvestment | 208.8800 | +14.35% | +8.84% | |
Candriam Equities L Biotech.C US... | reinvestment | 852.9000 | +15.86% | +13.77% | |
Candriam Equities L Biotech.C US... | paying dividend | 783.5000 | +15.82% | +13.66% |
Performance
YTD | +3.09% | ||
---|---|---|---|
6 Months | +16.32% | ||
1 Year | +15.82% | ||
3 Years | +13.66% | ||
5 Years | +49.95% | ||
Since start | +748.48% | ||
Year | |||
2023 | +7.13% | ||
2022 | -1.52% | ||
2021 | -2.69% | ||
2020 | +19.20% | ||
2019 | +34.92% | ||
2018 | -11.26% | ||
2017 | +26.62% | ||
2016 | -19.51% | ||
2015 | +8.10% |
Dividends
2023-04-28 | 3.92 USD |
2022-04-28 | 3.44 USD |
2021-04-28 | 5.10 USD |
2020-04-24 | 2.36 USD |
2019-04-26 | 2.90 USD |
2018-04-24 | 4.00 USD |
2017-04-25 | 2.50 USD |
2016-04-26 | 1.76 USD |
2015-04-28 | 8.00 USD |
2014-04-29 | 0.70 USD |
2013-04-26 | 0.70 USD |
2012-04-27 | 0.20 USD |
2011-04-29 | 0.20 USD |
2002-05-13 | 1.00 USD |